These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6156397)

  • 1. Butyryl derivatives of cyclic GMP interfere with the biological and the immunological properties of the pancreozymin-gastrin family of peptides.
    Robberecht P; Deschodt-Lanckman M; Woussen-Colle MC; De Neef P; Camus JC; Christophe J
    Mol Pharmacol; 1980 Mar; 17(2):268-74. PubMed ID: 6156397
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP.
    Collins SM; Abdelmoumene S; Jensen RT; Gardner JD
    Am J Physiol; 1981 Jun; 240(6):G466-71. PubMed ID: 6166201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble interaction between dibutyryl cyclic guanosine 3':5'-monophosphate and cholecystokinin: a possible mechanism for the inhibition of cholecystokinin activity.
    Miller LJ; Reilly WM; Rosenzweig SA; Jamieson JD; Go VL
    Gastroenterology; 1983 Jun; 84(6):1505-11. PubMed ID: 6301926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dibutyryl cyclic guanosine monophosphate, a competitive antagonist to cholecystokinin-pancreozymin, on gastric acid secretion in the isolated mouse stomach.
    Davison JS; Najafi-Farashah A
    Life Sci; 1982 Jul; 31(4):355-61. PubMed ID: 6128663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin inhibits gastrin release induced by antral infusion of cyclic nucleotides and bombesin in the pig.
    Linehan WM; Cooper CW; Wells SA
    Surg Forum; 1979; 30():337-8. PubMed ID: 231849
    [No Abstract]   [Full Text] [Related]  

  • 6. Dibutyryl cGMP: inhibitor of the effect of cholecystokinin and gastrin on the guinea pig gallbladder in vitro.
    Poitras P; Iacino D; Walsh JH
    Biochem Biophys Res Commun; 1980 Sep; 96(1):476-82. PubMed ID: 6254515
    [No Abstract]   [Full Text] [Related]  

  • 7. Antinociceptive action of the butyryl derivatives of cyclic guanosine 3':5'-monophosphate.
    Vocci FJ; Petty SK; Dewey WL
    J Pharmacol Exp Ther; 1978 Dec; 207(3):892-8. PubMed ID: 215745
    [No Abstract]   [Full Text] [Related]  

  • 8. Dibutyryl cyclic GMP, a competitive inhibitor of cholecystokinin/pancreozymin and related peptides in the gallbladder and ileum.
    Davison JS; Najafi-Farashah A
    Can J Physiol Pharmacol; 1981 Oct; 59(10):1100-4. PubMed ID: 6274490
    [No Abstract]   [Full Text] [Related]  

  • 9. The reactivity of mononucleotides with cholecystokinin/gastrin antisera.
    Rehfeld JF
    Regul Pept; 1983 Apr; 6(1):33-41. PubMed ID: 6867379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of enzyme secretion by the exocrine pancreas.
    Christophe J; Robberecht P; Deschodt-Lanckman M; Lambert M; Van Leemput-Coutrez M; Camus J
    Adv Cytopharmacol; 1974; 2():47-61. PubMed ID: 4374059
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol.
    Liddle RA; Goldfine ID; Williams JA
    Gastroenterology; 1984 Sep; 87(3):542-9. PubMed ID: 6204904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism by which dibutyryl cyclic guanosine monophosphate antagonizes the action of cholecystokinin.
    Gardner JD
    Gastroenterology; 1983 Jun; 84(6):1619-21. PubMed ID: 6301927
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of cholecystokinin receptors in rat pancreatic membranes by sulfhydryl reagents: protection by guanosine 5'-triphosphate (GTP) but not N2,O2-dibutyryl guanosine 3',5'-cyclic monophosphate (dibutyryl cGMP).
    Chang RS; Lotti VJ; Chen TB
    Biochem Pharmacol; 1984 Jul; 33(14):2334-5. PubMed ID: 6087823
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanisms by which dibutyryl cyclic GMP antagonizes the action of cholecystokinin.
    Miller LJ; Reilly WM; Rosenzweig SA; Jamieson JD; Go VL
    Gastroenterology; 1983 Jun; 84(6):1637-9. PubMed ID: 6301928
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo effects of pancreozymin, secretin, vasoactive intestinal polypeptide and pilocarpine on the levels of cyclic AMP and cyclic GMP in the rat pancreas.
    Robberecht P; Deschodt-Lanckman M; De Neef P; Borgeat P; Christophe J
    FEBS Lett; 1974 Jul; 43(2):139-43. PubMed ID: 4368803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthesis and biological activity of derivatives of guanosine 3', 5'-cyclic phosphate].
    Cai HY; Zhang LH
    Yao Xue Xue Bao; 1989; 24(10):726-32. PubMed ID: 2559577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Independence of the insulin effect from the guanosine-3',5'-monophosphate level in muscle tissue].
    Kudriavtseva NV; Vinogradova NA; Novikov IP; Nikol'skiĭ NN
    Tsitologiia; 1981 Dec; 23(12):1403-10. PubMed ID: 6277062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feeding elicited by injection of the cholecystokinin antagonist dibutyryl cyclic GMP into the cerebral ventricles of sheep.
    Della-Fera MA; Baile CA; Peikin SR
    Physiol Behav; 1981 May; 26(5):799-801. PubMed ID: 6267625
    [No Abstract]   [Full Text] [Related]  

  • 19. Actions of derivatives of cyclic nucleotides on dispersed acini from guinea pig pancreas. Discovery of a competitive antagonist of the action of cholecystokinin.
    Peikin SR; Costenbader CL; Gardner JD
    J Biol Chem; 1979 Jun; 254(12):5321-7. PubMed ID: 221466
    [No Abstract]   [Full Text] [Related]  

  • 20. Trophic effects of gastrin and cholecystokinin.
    Håkanson R; Axelson J; Ihse I; Sundler F
    Z Gastroenterol Verh; 1991 Mar; 26():265-9. PubMed ID: 1714169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.